Red Flags Detected

  • Delisting (new) — Company received Nasdaq deficiency notice for minimum bid price violation with October 2026 compliance deadline.
NASDAQ: LAB STANDARD BIOTOOLS INC. 10-Q

Standard BioTools sells SomaScan unit for $388M, cuts 20% of workforce, faces Nasdaq delisting risk

Filed May 6, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 6, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade LAB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov View full financials on EDGAR ↗

Generated by AI · Jun 2, 2026 2:53 AM